KT-333 is under clinical development by Kymera Therapeutics and currently in Phase I for Unspecified B-Cell Lymphomas.

KT has announced that it will be operating an offline pop-up called the 'Fanmade K-AI Idea Challenge' until January 5th, ...

KT Turner did not appreciate how Liberty head coach Ritchie McKay looked at one of his UT Arlington players during Saturday's ...

KT&G, South Korea's largest tobacco company, is a leading export powerhouse, capturing a growing market share in East and ...